|
US4228669A
(en)
*
|
1978-07-03 |
1980-10-21 |
Kysor Industrial Corporation |
Double cylinder lock with key retention
|
|
US4254648A
(en)
*
|
1979-02-21 |
1981-03-10 |
Norris Industries, Inc. |
Inner locking cylinder with captive key
|
|
US4315420A
(en)
*
|
1980-04-11 |
1982-02-16 |
Oliver Ronald N |
Retained key double cylinder deadbolt
|
|
US4369642A
(en)
*
|
1981-03-25 |
1983-01-25 |
Norris Industries, Inc. |
Detained key assembly
|
|
US4698989A
(en)
*
|
1986-09-26 |
1987-10-13 |
Kwikset Corporation |
Double cylinder lock assembly
|
|
US4793166A
(en)
*
|
1986-12-12 |
1988-12-27 |
Marks George R |
Multi-use lock cylinder
|
|
US5269162A
(en)
*
|
1990-10-12 |
1993-12-14 |
Emhart Inc. |
Cylinder lock
|
|
US5193372A
(en)
*
|
1991-04-19 |
1993-03-16 |
Dom-Sicherheitstechnik Gmbh & Co Kg |
Lock cylinder
|
|
US5140843A
(en)
*
|
1992-01-27 |
1992-08-25 |
Krueger Owen A |
Lock conversion mechanism
|
|
US5372021A
(en)
*
|
1992-10-30 |
1994-12-13 |
Ideaz International, Inc. |
Key control device and method therefor
|
|
US6207371B1
(en)
|
1996-10-04 |
2001-03-27 |
Lexicon Genetics Incorporated |
Indexed library of cells containing genomic modifications and methods of making and utilizing the same
|
|
US6855545B1
(en)
|
1996-10-04 |
2005-02-15 |
Lexicon Genetics Inc. |
Indexed library of cells containing genomic modifications and methods of making and utilizing the same
|
|
US5955355A
(en)
*
|
1997-03-27 |
1999-09-21 |
Millennium Pharmaceuticals, Inc. |
Chromosome 18 marker
|
|
US5866412A
(en)
*
|
1997-03-27 |
1999-02-02 |
Millennium Pharmaceuticals, Inc. |
Chromosome 18 marker
|
|
US5914394A
(en)
*
|
1997-03-27 |
1999-06-22 |
Millenium Pharmaceuticals, Inc. |
Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
|
|
US5939316A
(en)
*
|
1997-03-27 |
1999-08-17 |
Millennium Pharmaceuticals, Inc. |
Chromosome 18 marker
|
|
US5878613A
(en)
*
|
1997-08-06 |
1999-03-09 |
Secure Concepts, Ltd. |
Key retaining lock box
|
|
EP2298333A3
(fr)
|
1999-12-20 |
2012-05-02 |
Immunex Corporation |
Récepteur tweak
|
|
WO2001064882A2
(fr)
|
2000-02-29 |
2001-09-07 |
Millennium Pharmaceuticals, Inc. |
Recepteurs couples a une proteine g, numerotees 1983, 52881, 2398, 45449, 50289, et 52872, et utilisations correspondantes
|
|
US20080194022A1
(en)
*
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
EP1197550A3
(fr)
*
|
2000-08-25 |
2002-11-20 |
Pfizer Products Inc. |
Méthodes et compositions pour diagnostiquer et traiter des troubles associés à l'angiogenèse
|
|
US6803211B2
(en)
|
2000-08-25 |
2004-10-12 |
Pfizer Inc. |
Methods and compositions for diagnosing and treating disorders involving angiogenesis
|
|
US6729169B2
(en)
|
2001-03-27 |
2004-05-04 |
Randall L. Moore |
Dual cylinder deadbolt adjunct
|
|
US7229774B2
(en)
|
2001-08-02 |
2007-06-12 |
Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
EP2354156A3
(fr)
|
2001-08-14 |
2011-11-16 |
Sentigen Biosciences, Inc. |
Acides nucléiques et protéines de gènes de récepteur odorant OR83B d'insectes et utilisations associées
|
|
CA2459183A1
(fr)
*
|
2001-08-27 |
2003-03-06 |
Tularik Inc. |
Oncogenes amplifies et leur implication dans le cancer
|
|
EP2311960A3
(fr)
|
2001-08-29 |
2011-06-01 |
Genentech, Inc. |
Acides nucléiques Bv8 et polypeptides avec activité mitogénique
|
|
AU2002356898A1
(en)
*
|
2001-11-15 |
2003-06-10 |
Tularik Inc. |
Gene amplification and overexpression in cancer
|
|
CN1630514A
(zh)
|
2001-12-05 |
2005-06-22 |
贝勒医学院 |
通过调节交感神经紧张性控制骨形成的方法和组合物
|
|
WO2003053363A2
(fr)
|
2001-12-19 |
2003-07-03 |
Millennium Pharmaceuticals, Inc. |
Membres de la famille des diacylglycerol-acyltransferases 2 (dgat2) et leurs utilisations
|
|
EP1463834A4
(fr)
*
|
2001-12-20 |
2005-08-10 |
Tularik Inc |
Identification d'un gene amplifie et cible pour une intervention medicamenteuse
|
|
AU2003201741A1
(en)
|
2002-01-09 |
2003-07-24 |
Yusuke Nakamura |
Cancer profiles
|
|
EP1497642A2
(fr)
*
|
2002-03-19 |
2005-01-19 |
Tularik, Inc. |
Amplification de genes en cas de cancer
|
|
US20060052320A1
(en)
*
|
2002-05-06 |
2006-03-09 |
Limin Li |
Mammalian genes involved in rapamycin resistance and tumorgenesis annexin XIII genes
|
|
WO2004007747A2
(fr)
|
2002-07-12 |
2004-01-22 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Dosages de regroupement des nucleocapsides du virus ebola
|
|
US20050059011A1
(en)
*
|
2002-08-07 |
2005-03-17 |
Sin Wun Chey |
Amplification and overexpression of oncogenes
|
|
WO2004035970A1
(fr)
*
|
2002-10-15 |
2004-04-29 |
Geoffrey David Miles |
Ameliorations apportees a des verrous
|
|
WO2004046332A2
(fr)
*
|
2002-11-19 |
2004-06-03 |
Amgen Inc. |
Genes amplifies impliques dans un cancer
|
|
EP2112229A3
(fr)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Procédés d'identification du risque du cancer du sein et traitements associés
|
|
JP4912144B2
(ja)
|
2003-03-12 |
2012-04-11 |
ジェネンテック, インコーポレイテッド |
造血促進のためのbv8及び/又はeg−vegfの使用
|
|
US20060019256A1
(en)
*
|
2003-06-09 |
2006-01-26 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
AU2004249193A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Amgen Inc. |
Gene amplification and overexpression in cancer
|
|
WO2005074633A2
(fr)
*
|
2004-02-03 |
2005-08-18 |
The Regents Of The University Of Michigan |
Compositions et procédés permettant de caractériser, de réguler, de diagnostiquer et de traiter des cancers
|
|
US20070087008A1
(en)
|
2004-02-24 |
2007-04-19 |
The Government Of The United States Of America As |
Rab9a, rab11a, and modulators thereof related to infectious disease
|
|
JP4836942B2
(ja)
*
|
2004-04-30 |
2011-12-14 |
コーセラ, インコーポレイテッド |
リラキシンの調節による胎仔の発育の制御のための方法および組成物
|
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
|
AU2006259583A1
(en)
*
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US9957569B2
(en)
*
|
2005-09-12 |
2018-05-01 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
|
CA2814598A1
(fr)
|
2005-09-12 |
2007-03-22 |
The Regents Of The University Of Michigan |
Fusion geniques recurrentes dans le cancer de la prostate
|
|
WO2007047907A2
(fr)
*
|
2005-10-14 |
2007-04-26 |
The Regents Of The University Of Michigan |
Compositions de proteines dek et methodes d'utilisation de celles-ci
|
|
US20090175845A1
(en)
*
|
2005-10-25 |
2009-07-09 |
The Trustees Of Columbia University In The City Of New York |
Methods for identifying compounds that modulate phb domain protein activity and compositions thereof
|
|
CA2628255C
(fr)
*
|
2005-10-31 |
2016-04-19 |
The Regents Of The University Of Michigan |
Compositions et methodes pour traiter et diagnostiquer un cancer
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
CA2628221A1
(fr)
|
2005-10-31 |
2007-05-10 |
Oncomed Pharmaceuticals, Inc. |
Anticorps recepteurs fzd destines au traitement du cancer
|
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
|
JP5881270B2
(ja)
|
2006-01-05 |
2016-03-09 |
チルドレンズ メディカル センター コーポレーション |
Nfatの制御因子
|
|
US20080019961A1
(en)
*
|
2006-02-21 |
2008-01-24 |
Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
CA2654165A1
(fr)
|
2006-06-05 |
2007-12-13 |
Cancer Care Ontario |
Evaluation de risque pour cancer colorectal
|
|
US7572618B2
(en)
|
2006-06-30 |
2009-08-11 |
Bristol-Myers Squibb Company |
Polynucleotides encoding novel PCSK9 variants
|
|
US8978426B2
(en)
*
|
2006-11-07 |
2015-03-17 |
Pacific Lock Company |
Hidden shackle lock incorporating a “key-in-knob” (KiK) cylinder
|
|
WO2008092002A2
(fr)
*
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions et procédés pour le traitement et le diagnostic du cancer du pancréas
|
|
EP2243834A1
(fr)
|
2007-03-05 |
2010-10-27 |
Cancer Care Ontario |
Evaluation du risque de cancer colorectal
|
|
EP2581081A3
(fr)
|
2007-06-01 |
2013-07-31 |
The Trustees Of Princeton University |
Traitement d'infections virales par modulation de voies métaboliques de cellules hôtes
|
|
EP2173379B2
(fr)
|
2007-07-02 |
2023-07-05 |
Oncomed Pharmaceuticals, Inc. |
Compositions et procédés de traitement et de diagnostic d'un cancer
|
|
CA2692793C
(fr)
|
2007-07-06 |
2014-05-20 |
The Regents Of The University Of Michigan |
Rearrangements de genes mipol1 -etv1
|
|
EP2604701B1
(fr)
|
2007-07-06 |
2015-11-04 |
The Regents Of The University Of Michigan |
Fusions de gène récurrentes dans le cancer de la prostate
|
|
US7895865B2
(en)
*
|
2007-08-15 |
2011-03-01 |
Medeco Security Locks, Inc. |
Cylinder lock assembly with a tailpiece rotationally coupled to the cylinder plug
|
|
US8586081B2
(en)
*
|
2007-09-20 |
2013-11-19 |
University Of Massachusetts |
Detoxified recombinant botulinum neurotoxin
|
|
EP2271772B1
(fr)
*
|
2008-03-11 |
2014-07-16 |
Sequenom, Inc. |
Tests adn pour déterminer le sexe d'un bébé avant sa naissance
|
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
|
SG190568A1
(en)
|
2008-09-26 |
2013-06-28 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
|
KR20110093893A
(ko)
|
2008-11-11 |
2011-08-18 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
항-cxcr1 조성물 및 방법
|
|
KR20110111474A
(ko)
|
2009-01-09 |
2011-10-11 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
암에서의 반복적 유전자 융합체
|
|
EP2478120B1
(fr)
|
2009-09-17 |
2015-09-02 |
The Regents Of The University Of Michigan |
Fusions de gène récurrentes dans le cancer de la prostate
|
|
ES2577017T3
(es)
|
2009-12-22 |
2016-07-12 |
Sequenom, Inc. |
Procedimientos y kits para identificar la aneuploidia
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
|
US20110237461A1
(en)
|
2010-03-17 |
2011-09-29 |
The Regents Of The University Of Michigan |
Using phage epitopes to profile the immune response
|
|
CA2794674A1
(fr)
|
2010-04-01 |
2011-10-06 |
Oncomed Pharmaceuticals, Inc. |
Agents de liaison aux recepteurs frizzled et leurs utilisations
|
|
DE102010038105B4
(de)
*
|
2010-10-11 |
2012-05-24 |
André Haake |
Verfahren zur Kodierung eines Schlosses und Rohteil zur Durchführung dieses Verfahrens
|
|
US8945556B2
(en)
|
2010-11-19 |
2015-02-03 |
The Regents Of The University Of Michigan |
RAF gene fusions
|
|
AU2012249531B2
(en)
|
2011-04-29 |
2017-06-29 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
|
US8474289B2
(en)
|
2011-11-28 |
2013-07-02 |
Southern Company Services, Inc. |
Locking systems
|
|
EP2820129A1
(fr)
|
2012-03-02 |
2015-01-07 |
Sequenom, Inc. |
Méthodes et procédés d'évaluation non effractive de variations génétiques
|
|
US10504613B2
(en)
|
2012-12-20 |
2019-12-10 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
|
US20140093873A1
(en)
|
2012-07-13 |
2014-04-03 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
|
WO2014072832A2
(fr)
|
2012-10-18 |
2014-05-15 |
Oslo Universitetstssykehus Hf |
Biomarqueurs pour le cancer du col de l'utérus
|
|
AU2013334790A1
(en)
|
2012-10-23 |
2015-04-30 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using Wnt pathway-binding agents
|
|
AU2014212081A1
(en)
|
2013-02-04 |
2015-08-13 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a Wnt pathway inhibitor
|
|
US11060145B2
(en)
|
2013-03-13 |
2021-07-13 |
Sequenom, Inc. |
Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
US10107008B2
(en)
|
2013-09-15 |
2018-10-23 |
Pacific Lock Company |
Lock device
|
|
EP3736344A1
(fr)
|
2014-03-13 |
2020-11-11 |
Sequenom, Inc. |
Méthodes et procédés d'évaluation non invasive de variations génétiques
|
|
US10047547B2
(en)
|
2015-05-20 |
2018-08-14 |
Pacific Lock Company |
Locking link
|
|
WO2017087885A1
(fr)
|
2015-11-19 |
2017-05-26 |
Dana-Farber Cancer Institute, Inc. |
Méthodes d'identification de composés qui interfèrent avec les erreurs de routage des complexes baf liées à erg dans les cancers de la prostates liés à tmprss2-erg
|
|
US10619382B2
(en)
|
2016-02-29 |
2020-04-14 |
Pacific Lock Company |
Keyless lock system
|
|
USD930458S1
(en)
|
2016-09-30 |
2021-09-14 |
Pacific Lock Company |
Lock casing
|
|
US11497752B2
(en)
|
2018-01-30 |
2022-11-15 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
WO2020081588A1
(fr)
|
2018-10-17 |
2020-04-23 |
Dana-Farber Cancer Institute, Inc. |
Complexes de remodelage de la chromatine de la famille swi/snf et leurs utilisations
|
|
US12384776B2
(en)
|
2019-01-29 |
2025-08-12 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
US12509453B2
(en)
|
2019-01-29 |
2025-12-30 |
Foghorn Therapeutics Inc. |
BRM/BRG1 inhibitors and uses thereof
|
|
AU2021213811A1
(en)
|
2020-01-29 |
2022-07-28 |
Foghorn Therapeutics Inc. |
Compounds and uses thereof
|
|
US12383555B2
(en)
|
2020-05-20 |
2025-08-12 |
Foghorn Therapeutics Inc. |
Methods of treating cancers
|
|
US12606553B2
(en)
|
2021-03-09 |
2026-04-21 |
Foghorn Therapeutics Inc. |
Crystalline forms, compositions containing same, and methods of their use
|